Dan H Barouch1. 1. Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. dbarouch@bidmc.harvard.edu
Abstract
PURPOSE OF REVIEW: Recombinant adenovirus (rAd) vectors have emerged as promising vaccine platform technologies due to their capacity to elicit potent humoral and cellular immune responses to encoded antigens. These vectors are being explored as potential vaccine candidates for a variety of pathogens. This review summarizes current efforts to develop rAd vector-based vaccines for HIV-1. RECENT FINDINGS: In the phase 2b Step study, rAd5 vectors expressing clade B HIV-1 Gag, Pol, and Nef antigens failed to afford protection and may have resulted in increased HIV-1 acquisition in certain subgroups. Recent studies have explored the potential reasons for this failure and the utility of novel rAd vectors derived from non-Ad5 serotypes. SUMMARY: Current areas of active investigation include the development of alternative serotype rAd vectors, the incorporation of rAd vectors into heterologous vector prime-boost regimens, and the use of rAd vectors to express novel HIV-1 antigens. These HIV-1 vaccine candidates will be evaluated in clinical trials over the next several years.
PURPOSE OF REVIEW: Recombinant adenovirus (rAd) vectors have emerged as promising vaccine platform technologies due to their capacity to elicit potent humoral and cellular immune responses to encoded antigens. These vectors are being explored as potential vaccine candidates for a variety of pathogens. This review summarizes current efforts to develop rAd vector-based vaccines for HIV-1. RECENT FINDINGS: In the phase 2b Step study, rAd5 vectors expressing clade B HIV-1Gag, Pol, and Nef antigens failed to afford protection and may have resulted in increased HIV-1 acquisition in certain subgroups. Recent studies have explored the potential reasons for this failure and the utility of novel rAd vectors derived from non-Ad5 serotypes. SUMMARY: Current areas of active investigation include the development of alternative serotype rAd vectors, the incorporation of rAd vectors into heterologous vector prime-boost regimens, and the use of rAd vectors to express novel HIV-1 antigens. These HIV-1 vaccine candidates will be evaluated in clinical trials over the next several years.
Authors: Ronald Vogels; David Zuijdgeest; Richard van Rijnsoever; Eric Hartkoorn; Irma Damen; Marie-Pierre de Béthune; Stefan Kostense; Germaine Penders; Niels Helmus; Wouter Koudstaal; Marco Cecchini; Antoinette Wetterwald; Mieke Sprangers; Angelique Lemckert; Olga Ophorst; Björn Koel; Michelle van Meerendonk; Paul Quax; Laura Panitti; Jos Grimbergen; Abraham Bout; Jaap Goudsmit; Menzo Havenga Journal: J Virol Date: 2003-08 Impact factor: 5.103
Authors: S F Farina; G P Gao; Z Q Xiang; J J Rux; R M Burnett; M R Alvira; J Marsh; H C Ertl; J M Wilson Journal: J Virol Date: 2001-12 Impact factor: 5.103
Authors: Dan H Barouch; Jennifer Kunstman; Marcelo J Kuroda; Jörn E Schmitz; Sampa Santra; Fred W Peyerl; Georgia R Krivulka; Kristin Beaudry; Michelle A Lifton; Darci A Gorgone; David C Montefiori; Mark G Lewis; Steven M Wolinsky; Norman L Letvin Journal: Nature Date: 2002-01-17 Impact factor: 49.962
Authors: Neil M Flynn; Donald N Forthal; Clayton D Harro; Franklyn N Judson; Kenneth H Mayer; Michael F Para Journal: J Infect Dis Date: 2005-01-27 Impact factor: 5.226
Authors: Julie C Fitzgerald; Guang-Ping Gao; Arturo Reyes-Sandoval; George N Pavlakis; Zhi Q Xiang; Anthony P Wlazlo; Wynetta Giles-Davis; James M Wilson; Hildegund C J Ertl Journal: J Immunol Date: 2003-02-01 Impact factor: 5.422
Authors: Wing-Pui Kong; Lan Wu; Timothy C Wallstrom; Will Fischer; Zhi-Yong Yang; Sung-Youl Ko; Norman L Letvin; Barton F Haynes; Beatrice H Hahn; Bette Korber; Gary J Nabel Journal: J Virol Date: 2008-12-24 Impact factor: 5.103
Authors: Dan H Barouch; Maria G Pau; Jerome H H V Custers; Wouter Koudstaal; Stefan Kostense; Menzo J E Havenga; Diana M Truitt; Shawn M Sumida; Michael G Kishko; Janelle C Arthur; Birgit Korioth-Schmitz; Michael H Newberg; Darci A Gorgone; Michelle A Lifton; Dennis L Panicali; Gary J Nabel; Norman L Letvin; Jaap Goudsmit Journal: J Immunol Date: 2004-05-15 Impact factor: 5.422
Authors: Dan H Barouch; Jennifer Kunstman; Jennifer Glowczwskie; Kevin J Kunstman; Michael A Egan; Fred W Peyerl; Sampa Santra; Marcelo J Kuroda; Jörn E Schmitz; Kristin Beaudry; Georgia R Krivulka; Michelle A Lifton; Darci A Gorgone; Steven M Wolinsky; Norman L Letvin Journal: J Virol Date: 2003-07 Impact factor: 5.103
Authors: Kaimei Song; Diane L Bolton; Chih-Jen Wei; Robert L Wilson; Jeremy V Camp; Saran Bao; Joseph J Mattapallil; Leonore A Herzenberg; Leonard A Herzenberg; Charla A Andrews; Jerald C Sadoff; Jaap Goudsmit; Maria Grazia Pau; Robert A Seder; Pamela A Kozlowski; Gary J Nabel; Mario Roederer; Srinivas S Rao Journal: Proc Natl Acad Sci U S A Date: 2010-12-06 Impact factor: 11.205
Authors: Nicole Frahm; Allan C DeCamp; David P Friedrich; Donald K Carter; Olivier D Defawe; James G Kublin; Danilo R Casimiro; Ann Duerr; Michael N Robertson; Susan P Buchbinder; Yunda Huang; Gregory A Spies; Stephen C De Rosa; M Juliana McElrath Journal: J Clin Invest Date: 2011-12-27 Impact factor: 14.808
Authors: Mauricio A Martins; Damien C Tully; Young C Shin; Lucas Gonzalez-Nieto; Kim L Weisgrau; David J Bean; Rujuta Gadgil; Martin J Gutman; Aline Domingues; Helen S Maxwell; Diogo M Magnani; Michael Ricciardi; Nuria Pedreño-Lopez; Varian Bailey; Michael A Cruz; Noemia S Lima; Myrna C Bonaldo; John D Altman; Eva Rakasz; Saverio Capuano; Keith A Reimann; Michael Piatak; Jeffrey D Lifson; Ronald C Desrosiers; Todd M Allen; David I Watkins Journal: AIDS Res Hum Retroviruses Date: 2017-06-29 Impact factor: 2.205
Authors: Stephen R Walsh; Zoe Moodie; Andrew J Fiore-Gartland; Cecilia Morgan; Marissa B Wilck; Scott M Hammer; Susan P Buchbinder; Spyros A Kalams; Paul A Goepfert; Mark J Mulligan; Michael C Keefer; Lindsey R Baden; Edith M Swann; Shannon Grant; Hasan Ahmed; Fusheng Li; Tomer Hertz; Steven G Self; David Friedrich; Nicole Frahm; Hua-Xin Liao; David C Montefiori; Georgia D Tomaras; M Juliana McElrath; John Hural; Barney S Graham; Xia Jin Journal: J Infect Dis Date: 2015-10-15 Impact factor: 5.226
Authors: Monica Vaccari; Rabih Halwani; L Jean Patterson; Adriano Boasso; Jennifer Beal; Elzbieta Tryniszewska; Anna Hryniewicz; David Venzon; Elias K Haddad; Mohamed El-Far; Margherita Rosati; George N Pavlakis; Barbara K Felber; Saleh Al-Muhsen; Marjorie Robert-Guroff; Rafick-Pierre Sekaly; Genoveffa Franchini Journal: J Virol Date: 2013-01-16 Impact factor: 5.103